D. Keskin Et Al. , "Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.," Drug design, development and therapy , vol.10, pp.3355-3361, 2016
Keskin, D. Et Al. 2016. Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.. Drug design, development and therapy , vol.10 , 3355-3361.
Keskin, D., Sadri, S., & Eskazan, A. E., (2016). Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.. Drug design, development and therapy , vol.10, 3355-3361.
Keskin, Dilek, Sevıl SADRI, And Ahmet Emre EŞKAZAN. "Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.," Drug design, development and therapy , vol.10, 3355-3361, 2016
Keskin, Dilek Et Al. "Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.." Drug design, development and therapy , vol.10, pp.3355-3361, 2016
Keskin, D. Sadri, S. And Eskazan, A. E. (2016) . "Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.." Drug design, development and therapy , vol.10, pp.3355-3361.
@article{article, author={Dilek KESKİN Et Al. }, title={Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.}, journal={Drug design, development and therapy}, year=2016, pages={3355-3361} }